American College of Physicians on March 5, 2018 loosened the conditions tied to Type 2 Diabetes that afflict about 29 million Americans. Type 2 diabetic patients do not properly store or use glucose because not enough insulin hormone is produced or used properly.
Under the current guidance, patients are advised to have a hemoglobin A1C 6.5 to 7 percent, a measure of percentage of glucose in the blood in the preceding two to three months. Under the recommendation issued on March 5, 2018, it is okay to have hemoglobin A1C to be 7 to 8 percentage although every patient should consult with the physician to have a more "personalized" recommendation regime. ACP's new recommendation has not been approved by another respectable physician group, American Diabetes Association, or ADA.
Among the adverse outcome of stricter standards, ACP listed wooziness, lack of appropriate consciousness and genital fungal infection as side effects of so-called "hypoglycemic events". The recommendation was published on March 5, 2018 in the Annals of Internal Medicine.
Under the current guidance, patients are advised to have a hemoglobin A1C 6.5 to 7 percent, a measure of percentage of glucose in the blood in the preceding two to three months. Under the recommendation issued on March 5, 2018, it is okay to have hemoglobin A1C to be 7 to 8 percentage although every patient should consult with the physician to have a more "personalized" recommendation regime. ACP's new recommendation has not been approved by another respectable physician group, American Diabetes Association, or ADA.
Among the adverse outcome of stricter standards, ACP listed wooziness, lack of appropriate consciousness and genital fungal infection as side effects of so-called "hypoglycemic events". The recommendation was published on March 5, 2018 in the Annals of Internal Medicine.
